Last updated on August 2019

Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program

Brief description of study

The primary objective of this study is to establish a control population to assess performance of an investigational diagnostic test targeting lung neoplasms.

Detailed Study Description

Subjects will be participating in a lung cancer screening program at enrollment. Subjects will have a blood sample collected within 60 days of a low-dose CT scan (LDCT). Subjects with nodules present on the LDCT or subjects with a clean LDCT scheduled for a 12-month follow-up may have another blood draw at 12 months.

Clinical Study Identifier: NCT03628638

Find a site near you

Start Over

Meritus Center for Clinical Research

Hagerstown, MD United States
  Connect »